Cellceutix does not have a credibility problem. Far from it, the velocity of this company should be judged by the enormity of it's pipeline and the value of it's science along with the ongoing trials and not the daily SP.
Cellceutix will be partnered and or bought out when the time is right. To think anything else would be foolish. The company is well funded and there's no good reason to think otherwise. Where you would accept $10 a share now, I agree with Leo and I'm willing to wait for much more. In fact, I would be concerned with the acceptance of a low-ball offer at this time. GLTY.
GO CTIX